Robin Newman Joins Pro-ficiency Board of Directors
DURHAM, N.C., June 9, 2022 (Newswire.com) - Pro-ficiency continues to expand its thought leadership representation on their Board of Directors with the addition of Robin Newman, RN, MSN, EdD, CPNP.
"We hit the jackpot when Robin agreed to join our Board. The breadth of her leadership across the clinical trials landscape is astounding, but her doctorate in organizational learning and development means she really understands what we do, how it's done, and how it impacts clinical trials," said Pro-ficiency President and Founder Dave Hadden. "Her insights on how to apply our approach for medical devices is going to be a game-changer for us too."
"When you look at the root cause of many of the pervasive issues facing clinical trials, they stem from human understanding," said Dr. Newman. "I've been in leadership in clinical trials for decades and Pro-ficiency's approach is one of the few solutions I've seen that I truly believe can move that needle in a meaningful direction, for sponsors, for sites and for patients. Joining the Board of Directors was an easy decision."
For more than 25 years, Dr. Newman has dedicated her career to building better futures for patients through developing healthcare solutions in the medical device and biopharmaceutical industries. As a leader in business and philanthropy, Dr. Newman has her research roots firmly planted in the healthcare industry, beginning as a Clinical Research Coordinator and Pediatric Nurse Practitioner to her current role as Global VP for Clinical Affairs at Beckman Coulter Diagnostics and Life Sciences.
She holds both Bachelor's and Master's degrees in Nursing from the University of Texas at Austin and Arlington, where she was honored as a Distinguished Alumni, and a doctorate in Human & Organizational Learning and Development from The George Washington University.
Prior to joining Beckman Coulter, Dr. Newman served as the WW VP for Clinical Affairs and WW Vice President, Clinical, Preclinical and Medical Strategic R&D at Johnson & Johnson, the Director of the Office of Compliance at the Center for Devices and Radiological Health, US Food & Drug Administration, VP Quality, Regulatory, and Clinical Affairs at Siemens Healthcare Diagnostics, and Founder and CSO of MedTrials, a clinical research and regulatory consulting firm headquartered in Dallas, Texas. Dr. Newman has also served as member and Chair of the Board of Trustees for the Association of Clinical Research Professionals.
Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at pro-ficiency.com.